These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 39334524)

  • 1. APOBEC-1 Complementation Factor: From RNA Binding to Cancer.
    Wang L; Cheng Q
    Cancer Control; 2024; 31():10732748241284952. PubMed ID: 39334524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo.
    Snyder EM; McCarty C; Mehalow A; Svenson KL; Murray SA; Korstanje R; Braun RE
    RNA; 2017 Apr; 23(4):457-465. PubMed ID: 28069890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver.
    Blanc V; Xie Y; Kennedy S; Riordan JD; Rubin DC; Madison BB; Mills JC; Nadeau JH; Davidson NO
    RNA; 2019 Jan; 25(1):70-81. PubMed ID: 30309881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apobec-1 complementation factor regulates cell migration and apoptosis through Dickkopf1 by acting on its 3' untranslated region in MCF7 cells.
    Yan X; Li Q; Ni D; Xie Y; He Q; Wan Q; Liu Y; Lyu Z; Mao Z; Zhou Q
    Tumour Biol; 2017 Jun; 39(6):1010428317706218. PubMed ID: 28639893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.
    Blanc V; Navaratnam N; Henderson JO; Anant S; Kennedy S; Jarmuz A; Scott J; Davidson NO
    J Biol Chem; 2001 Mar; 276(13):10272-83. PubMed ID: 11134005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parent-of-origin effects of A1CF and AGO2 on testicular germ-cell tumors, testicular abnormalities, and fertilization bias.
    Carouge D; Blanc V; Knoblaugh SE; Hunter RJ; Davidson NO; Nadeau JH
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5425-33. PubMed ID: 27582469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
    Sowden MP; Lehmann DM; Lin X; Smith CO; Smith HC
    J Biol Chem; 2004 Jan; 279(1):197-206. PubMed ID: 14570923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing.
    Lau PP; Chan L
    J Biol Chem; 2003 Dec; 278(52):52988-96. PubMed ID: 14559896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
    Mehta A; Kinter MT; Sherman NE; Driscoll DM
    Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.
    Anant S; Henderson JO; Mukhopadhyay D; Navaratnam N; Kennedy S; Min J; Davidson NO
    J Biol Chem; 2001 Dec; 276(50):47338-51. PubMed ID: 11577082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
    Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
    Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.
    Anant S; Davidson NO
    Mol Cell Biol; 2000 Mar; 20(6):1982-92. PubMed ID: 10688645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apobec-1 Complementation Factor (A1CF) Inhibits Epithelial-Mesenchymal Transition and Migration of Normal Rat Kidney Proximal Tubular Epithelial Cells.
    Huang L; Wang H; Zhou Y; Ni D; Hu Y; Long Y; Liu J; Peng R; Zhou L; Liu Z; Lyu Z; Mao Z; Hao J; Li Y; Zhou Q
    Int J Mol Sci; 2016 Feb; 17(2):. PubMed ID: 26848653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of RNA Editing Activity of APOBEC1-A1CF and APOBEC1-RBM47 Complexes Reconstituted in HEK293T Cells.
    Wolfe AD; Arnold DB; Chen XS
    J Mol Biol; 2019 Mar; 431(7):1506-1517. PubMed ID: 30844405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
    Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.
    Anant S; Mukhopadhyay D; Sankaranand V; Kennedy S; Henderson JO; Davidson NO
    Am J Physiol Cell Physiol; 2001 Dec; 281(6):C1904-16. PubMed ID: 11698249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein.
    Anant S; MacGinnitie AJ; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14762-7. PubMed ID: 7782342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor.
    Lehmann DM; Galloway CA; Sowden MP; Smith HC
    Nucleic Acids Res; 2006; 34(11):3299-308. PubMed ID: 16820530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.
    Mehta A; Driscoll DM
    RNA; 2002 Jan; 8(1):69-82. PubMed ID: 11871661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of mRNA editing in yeast using a Gal4-apoB-Gal80 fusion transcript as the selectable marker.
    Lellek H; Welker S; Diehl I; Kirsten R; Greeve J
    J Biol Chem; 2002 Jun; 277(26):23638-44. PubMed ID: 11976346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.